N-acetylcysteine (NAC) shows promise to treat hereditary cystatin C amyloid angiopathy (HCCAA) HCCAA – a subtype of cerebral amyloid angiopathy (CAA) – is an ultra-rare Icelandic amyloid disease due to a mutation in the CST3 gene encoding for the protease inhibitor, cystatin C. HCCAA...
Hence then, the article about arctic therapeutics research suggests preventative strategy against hccaa was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Arctic Therapeutics research suggests preventative strategy against HCCAA )
Also on site :
- Crews respond to large fire at Denny Hamlin's parents' house in Stanley: Sources
- Reported tornado rips roofs off multiple homes in central Illinois
- Heidi Klum ditches bikini top to cozy up to husband Tom Kaulitz during St. Barths vacation